ST Premium
For just $1, you can unlock ST Grading’s top-rated stocks that consistently beat the market. Our AI-powered Smart Screener finds winning trades in seconds, helping you uncover hidden opportunities before others do.
© 2025 Stocks Telegraph All rights reserved.
Most stock quote data provided by Financial Modeling Prep
Based on recent data, AstraZeneca PLC (AZN) shows an Average True Range (ATR) of 1.52 and an Enterprise Value of 243.49B. Its average trading volume over the past 3 months is 4.6M, indicating liquidity. These fundamental metrics provide insight into AZN's underlying financial health and market activity.
AstraZeneca PLC (AZN) technical indicators as of August 15, 2025: the SMA 20 is 6.52%, SMA 50 at 8.55%, and SMA 200 at 11.4%. The RSI 14 value is 66.65, suggesting its current momentum. These technical analysis signals help assess AZN's price trends and potential future movements.
AstraZeneca PLC (AZN) stock performance overview as of August 15, 2025: The 52-week high is $87.68 (currently -10.5% below), and the 52-week low is $61.24 (currently 28.14% above). Over the past year, AZN's performance is -3.35%, compared to the S&P 500's 16.68% change.
According to market data, AstraZeneca PLC (AZN) stock's recent performance metrics show that over the last month, AZN is 11.97%, with a Year-to-Date (YTD) performance of 19.76%. Over the past year, the stock has seen a -3.35% change. These figures summarize AZN's price movements across various periods, reflecting its historical returns.
According to current financial data, AZN stock's P/E (TTM) ratio is 29.32, which compares to the S&P 500's P/E of 32.59. The sector median P/E is -1.24. Key valuation ratios for AZN, including P/S (4.30), P/B (5.44), and P/FCF (27.88), offer insights into how the company is valued relative to its earnings, sales, book value, and free cash flow.